You are here: Home » Companies » Results
Business Standard

Ipca Laboratories' PAT declines 26% to Rs 199.9 crore in December quarter

The company had posted a consolidated net profit of Rs 265.47 crore in the corresponding period last fiscal, Ipca Laboratories said in a regulatory filing

Topics
IPCA Laboratories | Q3 results | pharmaceutical firms

Press Trust of India  |  New Delhi 

Ipca

Ltd on Monday reported a 26 per cent decline in consolidated profit after tax to Rs 199.96 crore in the third quarter ended December 31, 2021.

The company had posted a consolidated net profit of Rs 265.47 crore in the corresponding period last fiscal, said in a regulatory filing.

Consolidated revenue from operations during October-December 2021 stood at Rs 1,430.47 crore as against Rs 1,409.83 crore in the year-ago quarter, it added.

Total expenses during the quarter were higher at Rs 1,182.74 crore, compared with Rs 1,098.71 crore a year ago. Cost of materials consumed stood at Rs 417.04 crore, up from Rs 393.51 crore in the same period last fiscal, the company said.

Overall, total formulations' revenue stood at Rs 992.77 crore in the third quarter as compared to Rs 954.34 crore in the year-ago period, up four per cent.

The domestic formulations segment's revenue grew 23 per cent in the third quarter to Rs 645.27 crore as compared with Rs 523.16 crore a year ago, the company said.

However, the active pharmaceutical ingredients (APIs) segment witnessed a 12 per cent decline in revenue at Rs 309.38 crore as against Rs 352.07 crore in the year-ago quarter, it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, February 14 2022. 20:33 IST
RECOMMENDED FOR YOU
.